Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Sanyou Bio Enters into Collaboration with Shanghai ZJ Bio-Tech to Advance Automated Development of Innovative Biologics

Tuesday, November 04, 2025

Sanyou Biopharmaceuticals and Shanghai ZJ BioTech Technology have entered into a strategic cooperation agreement focused on the automated development of innovative biologics

Akeso's Ivonescimab Achieves Fourth Breakthrough Therapy Designation in China for First-Line Triple-Negative Breast Cancer, Marking Major Milestone in Asian Biopharma Innovation

Monday, November 03, 2025

Akesos bispecific antibody ivonescimab has received its fourth Breakthrough Therapy Designation from Chinas NMPA for firstline treatment of triplenegative breast cancer reinforcing Asias leadership in oncology innovation

IntoCell and Xcellon Biologics Sign MoU to Broaden Access to Next-Generation ADC Technologies

Saturday, November 01, 2025

IntoCell Inca biotechnology company developing advanced payload and linker technologies for antibodydrug conjugates ADCs has entered into a strategic collaboration with Xcellon Biologics

Boryeong Signs Global CDMO Deal With Joulik Pharma To Supply Original Cytotoxic Anti-cancer Drug Alimita To 7 Southeast Asian Countries

Thursday, October 30, 2025

Boryeong expands its CDMO reach by partnering with Joulik Pharma to supply cytotoxic anticancer drug Alimita to seven Southeast Asian countries strengthening its RD and supply chain capabilities

Fosun Pharma Reports Surge in Innovative Drug Revenue and R&D Investment in 2025Q3 Financial Results

Wednesday, October 29, 2025

Fosun Pharma has reported significant growth in innovative drug revenues and RD investment for Q including key approvals expanded pipelines and industryfirst financial moves

Kazia Therapeutics to Seek FDA Type C Meeting on Overall Survival Data in Glioblastoma and Potential NDA Filing Under Project FrontRunner

Tuesday, October 28, 2025

Kazia Therapeutics Limited has announced plans to request a Type C meeting with the US Food and Drug Administration FDA to discuss overall survival OS results in newly diagnosed glioblastoma GBM patients

MicrobiotiX Receives IND Approval for Novel Bacteriophage Therapy MP101

Tuesday, October 28, 2025

MicrobiotiX Co Ltd a biotechnology company focused on developing innovative bacteriophagebased therapeutics has received Investigational New Drug IND approval from the Ministry of Food and Drug Safety

Alphamab Oncology Receives Approval to Initiate Phase III Clinical Trial of JSKN003 for HER2-Positive Advanced Colorectal Cancer in China

Monday, October 27, 2025

Alphamab Oncology gains NMPA approval to begin a pivotal Phase III trial of its biparatopic HERtargeting ADC JSKN for treatmentresistant colorectal cancer patients in China

HanchorBio Presents Phase 1 HCB101 Clinical Results at FACO 2025 Demonstrating Safety and Early Antitumor Activity

Friday, October 24, 2025

HanchorBio presented Phase results at FACO for its novel Fcengineered CDSIRP fusion protein HCB showing a strong safety profile and early antitumor activity in advanced cancer patients